KLHDC8A Activators

KLHDC8A Activators are a class of chemical compounds that influence the functional activity of KLHDC8A, a protein involved in ubiquitination, through pathways related to protein degradation and cytoskeletal dynamics. Compounds such as ubiquitin-activating enzyme E1 inhibitor and proteasome inhibitors like MG132 and Bortezomib can increase the levels of ubiquitinated proteins. This increase could enhance the functional activity of KLHDC8A by providing more substrates for ubiquitination. Additionally, inhibitors of the NEDD8-activating enzyme, like Pevonedistat, and cullin neddylation inhibitors disrupt cullin-RING ubiquitin ligase (CRL) functions, which may lead to a compensatory increase in ubiquitination activity mediated by KLHDC8A.

Cytoskeletal disruptors such as Cytochalasin D, Phalloidin, Jasplakinolide, and Withaferin A can alter the dynamics of actin filaments, enhancing the role of KLHDC8A if it is involved in ubiquitin-related processes associated with the actin cytoskeleton. In this context, the regulation of cytoskeletal structures provides a cellular environment that may necessitate the ubiquitination activity of KLHDC8A. Chloroquine, as an autophagy inhibitor, can prevent the degradation of ubiquitin.